Page last updated: 2024-09-05

5-hydroxy-2-n,n-dipropylaminotetralin and Schizophrenia

5-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Schizophrenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burnet, PW; Eastwood, SL; Harrison, PJ1

Other Studies

1 other study(ies) available for 5-hydroxy-2-n,n-dipropylaminotetralin and Schizophrenia

ArticleYear
5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1996, Volume: 15, Issue:5

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adult; Aged; Animals; Antipsychotic Agents; Autoradiography; Binding Sites; Brain; Female; Haloperidol; Humans; Ketanserin; Male; Middle Aged; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; RNA, Messenger; Schizophrenia

1996